Les Meilleurs doctors pour le traitement de cancer du foie en Israël - TOP-20 des médecins

Le Dr Pelles Sharon se spécialise dans les traitements de pointe du cancer du foie au centre médical Sourasky, notamment la chimiothérapie et les thérapies ciblées. Elle contribue activement à la recherche oncologique, garantissant des soins aux patients fondés sur des données probantes.

• Réaliser des résections hépatiques et des chimioembolisations pour le cancer du foie
• Être expert en thérapie ciblée et en approches d'immunothérapie
• Mener des recherches sur l'attitude des patients face aux essais cliniques

Le professeur Merimsky dirige l'unité des sarcomes au centre médical Sourasky, apportant une expertise approfondie dans le traitement du cancer du foie avec plus de 30 ans d'expérience.

• Spécialiste de l'oncologie des tissus mous et des os
• Membre de la faculté de l'ESMO pour les sarcomes
• Ancien président du département d'oncologie de l'université de Tel-Aviv
• Recherche approfondie en immunologie tumorale

Le Pr Arber se spécialise dans la prévention et le diagnostic des cancers gastro-intestinaux, et pas seulement dans leur traitement. Il dirige le centre de prévention du cancer au centre médical Sourasky.

• Plus de 30 ans d'expérience en oncologie gastro-intestinale
• Publication de plus de 300 articles de recherche sur les cancers gastro-intestinaux
• Diriger le centre de prévention du cancer à Ichilov
• Bourse de recherche et expérience au sein d'un hôpital de pointe aux États-Unis
• Membre de sociétés de recherche en oncologie internationales de premier plan

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Chef de la division d'oncologie du grand centre médical Sourasky de Tel Aviv – Le professeur Wolf dirige une équipe de haut niveau.

• Spécialisation en oncologie médicale et en médecine interne au centre médical Sheba
• Réalisation d'un stage postdoctoral au centre médical Cedar-Sinai de l'UCLA
• Membre de grandes sociétés d'oncologie, notamment l'ASCO et l'AACR
• Maître de conférences à la faculté de médecine Sackler de l'université de Tel-Aviv

Le Dr Ron Greenberg est un chirurgien abdominal de premier plan qui pratique des interventions de Whipple, tant ouvertes que mini-invasives, pour le cancer du foie.

• Avoir plus de 20 ans d'expérience chirurgicale
• Diriger le département de chirurgie colorectale du centre médical Sourasky
• Être expert en procédures complexes, y compris la technique de Whipple

L'un des meilleurs chirurgiens pour la procédure de Whipple en Israël, le Dr Klauzner est spécialisé dans les interventions gastro-intestinales et pancréatiques complexes. Il dirige actuellement le département de chirurgie du centre médical Sourasky (Ichilov).

• Plus de 45 ans d'expérience chirurgicale
• Expert en chirurgie des cancers du foie, colorectal et du pancréas
• Spécialisation dans la procédure complexe de Whipple
• Occuper un poste de direction dans un centre médical universitaire majeur

Plus de 28 ans d'expérience dans le traitement des cancers du foie et gastro-intestinaux – le Dr Ben-haim est spécialisé en oncologie chirurgicale complexe au centre médical Sourasky.

• Expert en chirurgie de Whipple pour le cancer du pancréas
• Concentré exclusivement sur l'oncologie gastro-intestinale
• Réaliser des interventions avancées pour les tumeurs du foie

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Le Dr Zalmanova est spécialisée en radiothérapie pour le cancer du foie au centre médical Assuta, un hôpital de premier plan en Israël.

• Expertise ciblée dans les traitements de radiothérapie
• Travailler dans un établissement médical de premier plan
• Se consacrer aux soins personnalisés des patients

Le Dr Alexander Beny dirige le service des tumeurs gastro-intestinales au centre médical Rambam, se spécialisant dans le traitement du cancer du foie.

• Oncologue certifié formé en oncologie médicale et en radiothérapie
• Expert en oncologie gastro-intestinale – dirige une clinique dédiée au cancer
• Formé aux techniques modernes de curiethérapie à l'ESTRO
• Parle couramment l'anglais et l'hébreu pour les patients internationaux

Chef de l'Institut d'Oncologie depuis 1994 – Tamar Jablonski-Perec dirige les soins oncologiques au centre médical Hadassah avec des décennies d'expertise.

• Spécialisation dans le traitement du cancer du foie avec une formation internationale
• Professeur d'oncologie à l'Université hébraïque
• Membre de multiples communautés internationales du cancer
• Récipiendaire de la prestigieuse bourse de la Hadassah Medical School

Le professeur Rifaat Safadi est spécialisé dans le traitement des maladies du foie en tant que chef de l'unité des maladies du foie au centre médical Hadassah. Ses travaux portent notamment sur l'immunomodulation de la fibrose hépatique.

• Plus de 30 ans d'expérience en gastroentérologie et en hépatologie
• Stage à l'école de médecine du Sinaï auprès du professeur Scott Friedman, expert des maladies du foie
• Lauréat de plusieurs prix pour ses recherches sur la fibrose hépatique
• Auteur de nombreux articles et membre d'associations internationales pour l'étude du foie
• Membre du comité de rédaction de la revue Clinical Science